SS-31 (Elamipretide) · Mitochondrial research context

SS-31, also referred to in the literature as elamipretide, is a synthetic mitochondria-targeting tetrapeptide. Research articles describe it as a member of the Szeto-Schiller (SS) family of peptides, characterized by an alternating aromatic-cationic structure that is reported to concentrate within the inner mitochondrial membrane.

Scientific interest in SS-31 centers on the mitochondrion as a subcellular target. The literature discusses it in the context of cellular bioenergetics research rather than as an established treatment, and this page reflects that framing without describing any therapeutic use.

Mechanistically, SS-31 is described in the literature as associating with cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane. Researchers discuss this interaction in relation to the organization of the electron transport chain and the efficiency of cellular energy production.

By binding cardiolipin, SS-31 is characterized in research as potentially influencing mitochondrial membrane structure and reducing certain reactive oxygen species under experimental conditions. Whether and how these laboratory observations translate to any clinical context has not been established here and remains a subject for qualified researchers and licensed providers to evaluate.

Regulatory status varies by country and can change. In the United States, SS-31 / elamipretide has been studied in investigational settings, and its availability and permitted uses should be confirmed against current official sources rather than assumed. Nothing on this page is a claim about approval, safety, or suitability for any purpose.

This material is provided for education only. A licensed provider determines appropriateness after a confidential intake. Education only · provider review required.